Navigation Links
Cyberonics Provides Business Update on Depression Clinical Trial
Date:1/7/2009

a>.

Safe harbor statement

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the use of forward-looking terminology, including "may," "believe," "will," "expect," "anticipate," "estimate," "plan," "intend," and "forecast," or other similar words. Statements contained in this press release are based upon information presently available to us and assumptions that we believe to be reasonable. We are not assuming any duty to update this information should those facts change or should we no longer believe the assumptions to be reasonable. Investors are cautioned that all such statements involve risks and uncertainties, including without limitation, statements concerning reducing the number of study subjects in the D-21 clinical study and completing follow-up on patients enrolled in the D-21 clinical study. Our actual results may differ materially. Important factors that may cause actual results to differ include, but are not limited to: continued market acceptance of VNS Therapy and sales of our product; the development and satisfactory completion of clinical trials and/or market test and/or regulatory approval of VNS Therapy for the treatment of other indications; satisfactory completion of post-market studies required by the U.S. Food and Drug Administration as a condition of approval for the treatment-resistant depression indication; adverse changes in coverage or reimbursement amounts by third-parties; intellectual property protection and potential infringement claims; maintaining compliance with government regulations and obtaining necessary government approvals for new indications; product liability claims and potential litigation; reliance on single suppliers and manufacturers for certain components; the accuracy of management's estimates
'/>"/>

SOURCE Cyberonics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Cyberonics Provides Update on Business Operations Following Hurricane Ike
2. Cyberonics Reports Strong Revenue Growth and Profitability in Fiscal 2008 Fourth Quarter
3. Vasogen Provides Corporate Update
4. Neurobiological Technologies Partner, Celtic Pharma, Provides Update on XERECEPT(R) Clinical Program and Planned Sale in 2009
5. Cornerstone Therapeutics Provides Update on Integration Activities and Issues 2008 Revenue Guidance
6. GeneNews provides Centocor access to its osteoarthritis program
7. ATS Medical Provides Update on US Commercialization of Its ATS 3f Aortic Bioprosthesis
8. YM BIOSCIENCES PROVIDES EU REGULATORY UPDATE
9. New Report Provides Expert Analysis of Recent Advances and Setbacks in Parkinsons Disease Drug Development
10. ZhenSpa.com provides Spa Enthusiasts Affordable Alternatives for Expensive Spa Treatments
11. New Radiation-Blocking Medical Garments Introduced at RSNA Meeting in Chicago : Demron-M Technology Provides Total Protection in a Lightweight, Durable, Flexible Fabric

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)... The FBI recently approved the Promega PowerPl...ing in or generating DNA records for the National ...on, WI USA (PRWEB) -- The FBI recently approved th... laboratories participating in, or generating DNA ... NDIS currently contains more than seven million p...
(Date:11/24/2009)...er24/PRNewswire-FirstCall/--Shireplc(LSE:SHP,NASD...pany,today,announcedthatithassubmittedaMAAtotheEur...ny,senzymereplacementtherapyindevelopment,forthetr...ng,applicationforvelaglucerasealfathathasbeensubmi...anada. , Basedonaglobalsupplyshortageofthecur...
(Date:11/24/2009)...ovember24/PRNewswire/--HealthRoboticstodayannounce...pofselected,investors.ThisrecentlyformedToronto-ba...nada,Inc.andwillmarket,install,andsupport,HealthRo...,revolutionaryproductofferingsi.v.STATION(TM),i.v....lsoprovideassistanceonan"asneeded,basis"toitsstrat...
(Date:11/24/2009)...4/PRNewswire-FirstCall/--CellTherapeutics,Inc.(CTI...AnnualPiperJaffrayHealthCareConference.Theconferen...el. ,, CTIwillpresentonTuesday,December1at11:00...stofCTI,spresentationwillbeavailableat www.cellthe...terwards. , ,PiperJaffrayHealthCareConference,New...
Breaking Biology Technology:NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Health Robotics Continues its Global Expansion With December 09 ASHP's Launch of Joint Venture in Canada 2
... African Ancestry Helps A-List Line Up...their Roots in Africa; RIse of consumer genetic te...n descent spawn trend in African Americans to trac...son. , Washington, DC (PR...t Barack Obama won,t have to grapple with in the O...
... Conn. Science fiction writers have long envision...e sun,s light. But, the forces of sunlight are too...een tried. Now a team led by researchers at the Y...hown that the force of light indeed can be harness...o nano-proportions. , Their work opens the door ...
... The new DNA Mini Portrait™ is t... New York, NY(PRWEB) November 26, 20... portraits made from the customers, DNA, launch DN... DNA Art that combines art, technology, beauty and... unique gifting solution for this holiday season t...
Other Biology Technology:Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama 2Growing Interest in DNA-Based Genetic Testing Among African American with Historic Election of President Elect Barack Obama 3'The photon force is with us': Harnessing light to drive nanomachines 2DNA 11, Creators of DNA Art, Introduces a More Affordable Line of Custom Portraits for this Year's Gift Giving Season 2
(Date:11/25/2009)... the Cell Death Research Laboratory in the Univers...rded the prestigious Johnson & Johnson Focused Fun... brain cell damage in Parkinson,s disease. The awa...pport of innovation and excellence in science, was...er this month at an event at the Hyatt Regency Hot...
(Date:11/25/2009)...e, the heart pumps some 250 million liters of bloo...uscle fibers of the heart have to be extremely dur...ttbauer, vice chair of the Department of Medicine ...rof. Dr. H. A. Katus), has discovered a protein th...t muscular unit, the sarcomere. In cooperation wit...
(Date:11/25/2009)...ay be just as vital to your health as what you eat...ogical Studies. Their experiments in mice revealed...genes in the liverthe body,s metabolic clearinghou...he body,s circadian clock as conventional wisdom h...ty of a large number of genes completely independe...
Breaking Biology News(10 mins):Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2New genetic cause of cardiac failure discovered 2Feeding the clock 2Feeding the clock 3CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 1CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 2CelebrityDiagnosis com Presents Famous Patients As Medical Lessons 49603 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 1KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 2KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 3KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 4KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 5KV Pharmaceutical Receives Letter From NYSE Regarding Delayed Filing of Its 2009 Annual Report on Form 10 K 49600 6A Pets Bite Can Pass on MRSA 49599 1A Pets Bite Can Pass on MRSA 49599 2
...optimize the cardiac function of patients with hea...atients might be at higher risk of dying suddenly ...ke University Medical Center. , Besides maintainin...se CRT-D (cardiac resynchronization therapy with d...new view of subtle changes in a key measurement of...
...f Liverpool have discovered how fish have evolved ... at different water depths. , A research team led...ist at the School of Biological Sciences, has reve...eveloped a way of floating at certain water levels...nvestigated the mechanism that allows fishes to ke...
...iversity scientists have "programmed" cells to mak...d high-resolution, deep-tissue imaging of gene exp... of Nature Medicine, hold considerable promise for...eld of molecular therapeutics and for monitoring t...or 20 years it has been the chemist,s job to devel...
Other Biology News:Implanted Devices Detect High-Risk Heart Failure Patients 2Implanted Devices Detect High-Risk Heart Failure Patients 3Scientists discover how fish evolved to float at different sea depths 2Carnegie Mellon scientists develop tool that uses MRI to visualize gene expression in living animals 2
... value of your microarray data using Asuragens bio...ed from consultation to extensive data analysis us...tise in combination with the Gene Expression Profi...ts., ,Normalization and basic statistical anal...
CORNING ROLLER BOTTLE WITH CELLBIND, 1700CM2, STERILE from Sigma-Aldrich
... (OSM) is a pleiotropic cytokine produced by activ.... OSM inhibits the growth of some tumour and norma...and Kaposis sarcoma cell proliferation, cytokine r...protein receptor expression on hepatoma cells. Mou...
...syringe pump series combines Harvard Apparatuss be...ce and a wide range of configuration options. A lo...nsions of syringes from all the major manufacturer...e pertinent information from across the lab. All m...
Biology Products: